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Abstract
Background:  Pneumocystis jirovecii, formerly named Pneumocystis carinii, is one of the most
common opportunistic infections in human immunodeficiency virus (HIV)-infected patients.
Case presentations: We encountered two cases of spontaneous pneumomediastinum with
subcutaneous emphysema in HIV-infected patients being treated for Pneumocystis jirovecii
pneumonia with trimethoprim/sulfamethoxazole.
Conclusion: Clinicians should be aware that cystic lesions and bronchiectasis can develop in spite
of trimethoprim/sulfamethoxazole treatment for P. jirovecii pneumonia. The newly formed
bronchiectasis and cyst formation that were noted in follow up high resolution computed
tomography (HRCT) but were not visible on HRCT at admission could be risk factors for the
development of pneumothorax or pneumomediastinum with subcutaneous emphysema in HIV-
patients.
Background
Pneumocystis jirovecii, formerly named Pneumocystis carinii,
is one of the most common opportunistic infections in
human immunodeficiency virus (HIV)-infected patients
[1,2]. Spontaneous pneumothorax has been recognized as
a frequent complication in patients with P. jirovecii pneu-
monia (PCP) since it was first described in 1984 [3], and
pneumomediastinum is an uncommon complication
associated with pneumothorax in the aforementioned
population. We report two cases of spontaneous pneumo-
mediastinum with subcutaneous emphysema in HIV-
infected patients being treated for P. jirovecii pneumonia
with trimethoprim/sulfamethoxazole.
Case presentation
Case 1
A 33-year-old man presented with fever, dyspnea, and
odynophagia. Five months prior to admission, the patient
had been treated for dental caries at a local hospital, and
at that time examination revealed seropositivity for
human immunodeficiency virus. On admission, tempera-
ture was 39.0'C, pulse 92 beats per minute, respiratory
rate 20 breaths per minute and blood pressure 130/80
mmHg. Physical examination revealed oral thrush, con-
sistent with findings of extensive esophageal candidiasis
in endoscopic gastroduodenscopy performed five days
before admission. Laboratory data on admission revealed
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a WBC count of 1,760/uL, Hb 10.9 g/dL, and platelet
count of 297,000/uL. Arterial blood gas analysis while
breathing room air revealed PaO2 of 48.0 mmHg, PaCO2
of 32.7 mmHg, and saturation of 88.5%, and the calcu-
lated (A-a)DO2 was 53.7. CD4 count and HIV viral load
were 4/uL and 130,000 IU/mL, respectively. Diffuse bilat-
eral infiltrates of both lung fields were noted, and no
cystic lesions were observed on the chest X-ray and high
resolution computed tomography (HRCT) taken on
admission. Bronchoscopic alveolar lavage for diagnosis of
P. jirovecii was carried out, and microscopic examination
of the bronchoalveolar lavage fluid obtained showed P.
jirovecii; no other microorganisms were detected by cul-
ture. Treatment with trimethoprim/sulfamethoxazole,
fluconazole and corticosteroids at standard dosages was
started. The patient had never been on HAART therapy
prior to admission. HAART therapy was added to the
treatment on the 8th hospital day. During the treatment
with trimethoprim/sulfamethoxazole, pancytopenia
worsened. Bone marrow biopsy revealed inflamed mar-
row and partial necrosis. Granulocyte colony stimulating
factor was used without avail. On the 22nd hospital day,
the chest X-ray obtained as the patient's hypoxemia wors-
ened revealed pneumomediastinum. HRCT showed
newly formed cystic lesions in both lung fields. Pneumo-
mediastinum was treated conservatively with high oxygen
supply. CD4 cell count and HIV levels were not followed
during treatment. However, as the general condition of
the patient deteriorated, the patient was started on intra-
venous pentamidine on the 23rd hospital day. On the 25th
hospital day, his oxygen requirement increased. Without
intubation, as the patient and guardian refused the patient
being put on a ventilator due to multiple economical and
sociological reasons, the patient died on the 26th hospital
day.
Case 2
A 48-year-old man presented with insidious dyspnea that
had developed over a period of 2 months. The patient had
been seropositive for human immunodeficiency virus in
2005 in a routine physical examination for a job position
as a sailor. He was on zidovudine and didanosine for 8
months but stopped taking these antiretroviral agents at
another hospital for economic reasons. On admission,
temperature was 38.2'C, pulse 96 beats per minute, respi-
ratory rate 22 breaths per minute, and blood pressure
100/60 mmHg. Physical examination was normal except
for decreased breathing sound in both lung fields. Labora-
tory data showed a WBC count of 11,010/uL, Hb 13.6 g/
dL, a platelet count of 425,000/uL, and LDH of 1,095 U/
L. Arterial blood gas analysis in room air demonstrated
PaO2 of 54.1 mmHg, PaCO2 of 34.4 mmHg, and satura-
tion of 89.9%, and the calculated (A-a)DO2 was 45.5.
CD4 count and HIV viral load were 21/uL and 260,000
IU/mL, respectively. Chest X-ray on admission revealed
diffuse ground glass opacity in both lung fields. HRCT
showed interlobular septal thickening of the bronchus
and bronchioles without any cyst formation (Figure 1).
Microscopic examination of bronchoalveolar lavage
revealed P. jiroveci, and Staphylococcus aureus was detected
by culture. The patient met the criteria of respiratory fail-
ure [PaO2 less than 70 mmHg or (A-a)DO2 more than 35
mmHg] and corticosteroids were co-administered with
trimethoprim/sulfamethoxazole. On hospital day 4 the
patient developed sudden chest pain radiating to the
shoulder and neck. Chest X-ray, electrocardiography, and
arterial blood gas analysis were performed. The chest X-
ray revealed air lining the cardiac border, indicating devel-
opment of pneumomediastinum. HRCT revealed newly
developed cystic changes, bronchiectatic change, and
parenchymal tear (Figure 1). The pneumomediastinum
was treated conservatively with administration of high
oxygen supply without the need for invasive procedures.
On hospital day 10, HAART was started with lopinavir/
ritonavir, lamivudine, and zidovudine. On hospital day
13, follow up HRCT revealed more aggravated pneumo-
mediastinum, bronchiectasis and parenchymal tear in the
lingular division of the left upper lobe. Trimethoprim/sul-
famethoxazole was changed to intravenous pentamidine.
The patient experienced nausea, vomiting, and hypoglyc-
emia on pentamidine, leading to a further change of anti-
biotics to primaquine and clindamycin. The patient's
dyspnea improved and no particular complications were
observed. The patient was discharged on the 42nd hospital
day and is being followed up in the outpatient clinic.
Discussion
The overall incidence of P. jirovecii pneumonia has
decreased with the use of highly active antiretroviral ther-
apy [4]. However, approximately 85% of patients with
advanced HIV infections continue to experience P. jirovecii
pneumonia in the course of their disease when manage-
ment is inadequate [5]. The most common radiographic
finding in P. jirovecii pneumonia is the presence of diffuse,
bilateral perihilar interstitial infiltrates (ground-glass
opacity) in both lungs [6]. Atypical radiographic manifes-
tations of PCP include cystic spaces and bullae, adenopa-
thy, pleural effusions and pneumothorax [7-10]. The exact
mechanism behind the development of the pulmonary
cysts and P. jirovecii is not yet known. However, various
mechanisms have been proposed including direct lung
destruction by P. jirovecii, over-distension of the lungs
caused by obstructive bronchiolitis acting as a ball-valve
(inflammatory exudates in the small bronchioles), inter-
stitial emphysema and abnormal remodeling of pulmo-
nary architecture due to interstitial fibrosis, and release of
elastase and other proteolytic enzymes [5,10-12]. A review
of the literature indicates that the development of sponta-
neous pneumomediastinum with subcutaneous emphy-
sema in HIV patients is rare. The pathophysiology ofBMC Infectious Diseases 2009, 9:171 http://www.biomedcentral.com/1471-2334/9/171
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pneumomediastinum depends on a pressure gradient
between the alveoli and the lung interstitium; this leads to
alveolar rupture, and consequently air in the interstitial
space flows towards the mediastinum along a pressure
gradient between the lung periphery and the mediasti-
num [13]. Other mechanisms leading to this outcome
have been attributed to gas-producing microorganisms
present in the pneumomediastinum, and rupture of the
mucosal barrier of the esophagus or tracheobronchial tree
[14]. However, how the presence of P. jirovecii contributes
to the development of pneumomediastinum is unknown.
Spontaneous pneumothorax occurs in as many as 35% of
patients with active cystic P. jirovecii pneumonia [8]. Even
though it is not known exactly how the disease progresses
to pneumothorax or pneumomediastinum, it is impor-
tant to identify associated factors and be able to predict
their occurrence. A history of cigarette smoking, pentami-
dine aerosol treatment, and detection of pneumatoceles
by chest radiography, are reported risk factors associated
with spontaneous pneumothorax [15,16].
In relation to the aforementioned risk factors, a 22 pack-
year history of smoking was noted in one of our two
patients. Pneumatoceles or cysts were not seen on the
chest X-rays or HRCT scans taken on admission in either
patient. However, cystic lesions and bronchiectasis devel-
oped de novo in spite of the standard trimethoprim/sul-
famethoxazole treatment, and they are presumed to have
developed into pneumomediastinum with subcutaneous
emphysema [17]. Staphylococcus aureus that was cultured
in the second case may have attributed to the develop-
ment of pneumomediastinum [18]. However, the use of
trimethoprim/sulfamethoxazole was adequate for treat-
fRadiological findings of an 48-year-old man with Pneumocystis jirovecii pneumonia on admission and at follow up Figure 1
Radiological findings of an 48-year-old man with Pneumocystis jirovecii pneumonia on admission and at follow 
up. A. Computed tomography on admission reveals diffuse bilateral infiltrates. B. Diffuse ground glass opacities are noted on 
both lung fields on admission. C. High resolution computed tomography reveals newly developed bronchiectatic changes 
(white arrow) and parenchymal tears (black arrow) at follow up. D. Pneumomediastinum (black arrow) and cystic changes 
(white arrow) are seen at follow up.BMC Infectious Diseases 2009, 9:171 http://www.biomedcentral.com/1471-2334/9/171
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ing Staphylococcus aureus without the need for an addi-
tional antibiotic [19]. Treatment of spontaneous
pneumomediastinum is generally limited to observation
without the need for invasive measures [20]. However, in
the above patients, P. jirovecii pneumonia may have been
an underlying cause to the development of pneumomedi-
astinum. Therefore, the standard trimethorpim/sulfame-
thoxazole was analyzed as a treatment failure warranting
a change of antibiotics to pentamidine.
There is no guideline regarding the treatment of the acute
phase of P. jirovecii pneumonia in HIV-infected patients
with HAART. However, administration of HAART therapy
early in the acute phase of P. jirovecii pneumonia was done
in both patients as improved survival rates in HIV-infected
patients with severe P. jirovecii pneumonia was associated
with HAART therapy [21,22]. Although the developement
of pneumothorax was not anticipated in our patients
when HAART therapy was initiated, Morris et al reported
decreased rates of pneumothorax development in P.
jirovecii  infected HIV-patients receiving HAART ther-
apy[21]. The possible contribution of antiretroviral ther-
apy to the clinical worsening of the patients was
considered. Wislez et al reported of acute respiratory fail-
ure following HAART in P. jirovecii pneumonia due to
immune reconstitution inflammatory syndrome [23].
HRCT of both patients in this study did not reveal any
findings relevant to the development of acute respiratory
failure.
The occurrence of newly formed cystic lesions or bron-
chiectasis despite treatment may be risk factors for the
development of pneumothorax or pneumomediastinum
with subcutaneous emphysema in HIV-patients. There-
fore close follow up with HRCT in HIV-patients with P.
jirovecii pneumonia might assist in predicting the develop-
ment of pneumothorax or pneumomediastinum. Our
findings suggest that clinicians should be aware of the
clinical importance of newly formed cystic lesions and
bronchiectasis for the development of pneumomediasti-
num and pneumothorax in P. jirovecii pneumonia.
Conclusion
In conclusion, clinicians should be aware that cystic
lesions and bronchiectasis can develop in spite of trimeth-
oprim/sulfamethoxazole treatment for P. jirovecii pneu-
monia. Newly formed bronchiectasis and cyst formation
may be risk factors for the development of pneumomedi-
astinum with subcutaneous emphysema.
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